Clinical Trial Update: Electronic Cigarettes as a Harm Reduction Strategy Among People With Opioid Use Disorder on Buprenorphine [NA]

View source ↗

Summary

Clinical trial evaluating electronic cigarettes as a harm-reduction strategy for people with opioid use disorder on buprenorphine, comparing tobacco-flavored an…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Opioid Use Disorder
• Tobacco Use Disorder

Drugs mentioned

• Electronic cigarettes (electronic nicotine delivery system)

Snippet

Sponsor: Prisma Health-Upstate | Conditions: Tobacco-flavored EC, Sweet-Cooling EC | NA | Status: NOT_YET_RECRUITING